Christopher L. Hall

4.0k total citations
62 papers, 2.8k citations indexed

About

Christopher L. Hall is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher L. Hall has authored 62 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher L. Hall's work include Bone health and treatments (12 papers), Prostate Cancer Treatment and Research (12 papers) and Wnt/β-catenin signaling in development and cancer (10 papers). Christopher L. Hall is often cited by papers focused on Bone health and treatments (12 papers), Prostate Cancer Treatment and Research (12 papers) and Wnt/β-catenin signaling in development and cancer (10 papers). Christopher L. Hall collaborates with scholars based in United States, United Kingdom and Australia. Christopher L. Hall's co-authors include Evan T. Keller, Robert S. Munford, Jinlu Dai, Anna Bafico, Stuart A. Aaronson, P D Rick, Shelly R. Peyton, Luc Van Kaer, Sona Kang and Ormond A. MacDougald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Christopher L. Hall

61 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher L. Hall United States 29 1.2k 1.0k 550 413 299 62 2.8k
Rainer Wiewrodt Germany 35 1.7k 1.4× 1.1k 1.1× 983 1.8× 628 1.5× 294 1.0× 97 3.8k
John Pedersen Australia 34 1.6k 1.3× 752 0.7× 854 1.6× 439 1.1× 315 1.1× 90 3.6k
Itaru Kato Japan 33 1.5k 1.3× 591 0.6× 225 0.4× 751 1.8× 302 1.0× 141 3.8k
Yoshikazu Yonemitsu Japan 38 2.3k 1.9× 1.2k 1.2× 567 1.0× 942 2.3× 194 0.6× 158 4.7k
Cheryl L. Jorcyk United States 30 1.3k 1.1× 1.1k 1.1× 262 0.5× 740 1.8× 103 0.3× 67 3.2k
Sulma I. Mohammed United States 28 903 0.8× 680 0.7× 628 1.1× 138 0.3× 137 0.5× 74 2.9k
Maki Tanaka Japan 28 886 0.8× 1.1k 1.1× 293 0.5× 486 1.2× 133 0.4× 192 3.2k
Benjamin Swanson United States 24 2.0k 1.7× 1.6k 1.5× 404 0.7× 1.0k 2.5× 291 1.0× 62 3.8k
R.M. MACKIE United Kingdom 31 868 0.7× 1.9k 1.9× 467 0.8× 609 1.5× 123 0.4× 115 3.7k
Harvey Dosik United States 22 1.7k 1.5× 556 0.5× 275 0.5× 481 1.2× 176 0.6× 122 4.1k

Countries citing papers authored by Christopher L. Hall

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Hall more than expected).

Fields of papers citing papers by Christopher L. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Hall. The network helps show where Christopher L. Hall may publish in the future.

Co-authorship network of co-authors of Christopher L. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Hall. A scholar is included among the top collaborators of Christopher L. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Hall. Christopher L. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Christopher L., et al.. (2024). Intracellular delivery of oncolytic viruses with engineered Salmonella causes viral replication and cell death. iScience. 27(6). 109813–109813. 8 indexed citations
2.
3.
4.
Dessel, Nele Van, Christopher L. Hall, Abhinav Sharma, et al.. (2021). Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases. Nature Communications. 12(1). 6116–6116. 112 indexed citations
5.
Ng, Chau Yee, et al.. (2019). Higher risk breast screening: cancer detection rates, recall rates, and attendance rates in Northern Ireland. Clinical Radiology. 74(8). 654.e1–654.e5. 3 indexed citations
6.
Cairns, Michelle, Mark D. Preston, Christopher L. Hall, et al.. (2016). Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages. Journal of Clinical Microbiology. 55(3). 865–876. 44 indexed citations
7.
Day, Kathleen C., Guadalupe Lorenzatti Hiles, Molly Kozminsky, et al.. (2016). HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Research. 77(1). 74–85. 145 indexed citations
8.
Yu, Chunyan, Jill M. Keller, Joseph L. Sottnik, et al.. (2013). Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer. Oncogene. 33(19). 2464–2477. 19 indexed citations
9.
Sottnik, Joseph L., Stephanie Daignault‐Newton, Xiaotun Zhang, et al.. (2012). Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis. Clinical & Experimental Metastasis. 30(5). 569–578. 79 indexed citations
10.
11.
Hall, Christopher L., et al.. (2010). p21CIP-1/WAF-1 Induction Is Required to Inhibit Prostate Cancer Growth Elicited by Deficient Expression of the Wnt Inhibitor Dickkopf-1. Cancer Research. 70(23). 9916–9926. 41 indexed citations
12.
Jung, Younghun, Yusuke Shiozawa, Jianhua Wang, et al.. (2009). Expression of PGK1 by Prostate Cancer Cells Induces Bone Formation. Molecular Cancer Research. 7(10). 1595–1604. 25 indexed citations
13.
Kasina, S., Peggy Scherle, Christopher L. Hall, & Jill A. Macoska. (2009). ADAM‐mediated amphiregulin shedding and EGFR transactivation. Cell Proliferation. 42(6). 799–812. 45 indexed citations
14.
Dai, Jinlu, Christopher L. Hall, June Escara‐Wilke, et al.. (2008). Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms. Cancer Research. 68(14). 5785–5794. 119 indexed citations
15.
Hall, Christopher L., Stephanie Daignault, Rajal B. Shah, Kenneth J. Pienta, & Evan T. Keller. (2008). Dickkopf‐1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. The Prostate. 68(13). 1396–1404. 116 indexed citations
16.
Keller, Evan T., Jinlu Dai, June Escara‐Wilke, et al.. (2007). New trends in the treatment of bone metastasis. Journal of Cellular Biochemistry. 102(5). 1095–1102. 18 indexed citations
17.
Hall, Christopher L. & Evan T. Keller. (2006). The role of Wnts in bone metastases. Cancer and Metastasis Reviews. 25(4). 551–558. 64 indexed citations
18.
Smith, P.M., et al.. (2005). GyPSM-S: A synthesis model for fully-coupled geodynamic and petrological flow calculations related to subduction. AGU Fall Meeting Abstracts. 2005. 1 indexed citations
19.
Hall, Christopher L., Sona Kang, Ormond A. MacDougald, & Evan T. Keller. (2005). Role of wnts in prostate cancer bone metastases. Journal of Cellular Biochemistry. 97(4). 661–672. 128 indexed citations
20.
Hall, Christopher L., Rachel Tsan, Gabriele Mugnai, et al.. (2003). Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase‐type plasminogen activator (u‐PA). The Prostate. 59(2). 167–176. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer Wiewrodt Breakdown of academic impact, for papers by John Pedersen Breakdown of academic impact, for papers by Itaru Kato Breakdown of academic impact, for papers by Yoshikazu Yonemitsu Breakdown of academic impact, for papers by Cheryl L. Jorcyk Breakdown of academic impact, for papers by Sulma I. Mohammed Breakdown of academic impact, for papers by Maki Tanaka Breakdown of academic impact, for papers by Benjamin Swanson Breakdown of academic impact, for papers by R.M. MACKIE Breakdown of academic impact, for papers by Harvey Dosik
Rankless by CCL
2026